
AI's Magic Cycle
Linkedin: Here's some of what innovators are thinking about with AI research today
Artificial Intelligence concept - 3d rendered image.
When people talk about the timeline of artificial intelligence, many of them start in the 21st century.
That's forgivable if you don't know a lot about the history of how this technology evolved. It's only in this new millennia that most people around the world got a glimpse of what the future holds with these powerful LLM systems and neural networks.
But for people who have been paying attention and understand the history of AI, it really goes back to the 1950s.
In 1956, a number of notable computer scientists and mathematicians met at Dartmouth to discuss the evolution of intelligent computation systems.
And you could argue that the idea of artificial intelligence really goes back much further than that. When Charles Babbage made his analytical engine decades before, even rote computation wasn't something that machines could do.
But when the mechanical became digital, and data became more portable in computation systems, we started to get those kinds of calculations and computing done in an automated way.
Now there's the question of why artificial intelligence didn't come along in the 1950s, or in the 1960s, or in the 1970s.
'The term 'Artificial Intelligence' itself was introduced by John McCarthy as the main vision and ambition driving research defined moving forward,' writes Alex Mitchell at Expert Beacon. '65 years later, that pursuit remains ongoing.'
What it comes down to, I think most experts would agree, is that we didn't have the hardware. In other words, you can't build human-like systems when your input/output medium is magnetic tape.
But in the 1990s, the era of big data was occurring, and the cloud revolution was happening. And when those were done, we had all of the systems we needed to host LLM intelligence.
Just to sort of clarify what we're talking about here, most of the LLMs that we use work on the context of next-word or next-token analysis – they're not sentient, per se, but they're using elegant and complex data sets to mimic intelligence.
And to do that, they need big systems. That's why the colossal data centers are being built right now, and why they require so much energy, so much cooling, etc.
At an Imagination in Action event this April, I talked to Yossi Mathias, a seasoned professional with 19 years at Google who is the head of research at Google, about research there and how it works.
He talked about a cycle for a research motivation that involves publishing, vetting and applying back to impact.
But he also spoke to that idea that AI really goes back father than most people think.
'It was always there,' he said, invoking the idea of the Dartmouth conference and what it represented. 'Over the years, the definition of AI has shifted and changed. Some aspects are kind of steady. Some of them are kind of evolving.'
Then he characterized the work of a researcher, to compare motives for groundbreaking work.
'We're curious as scientists who are looking into research questions,' he said, 'but quite often, it's great to have the right motivation to do that, which is to really solve an important problem.'
'Healthcare, education, climate crisis,' he continued. 'These are areas where making that progress, scientific progress …actually leads into impact, that is really impacting society and the climate. So each of those I find extremely rewarding, not only in the intellectual curiosity of actually addressing them, but then taking that and applying it back to actually get into the impact that they'd like to get.'
Ownership of a process, he suggested, is important, too.
'An important aspect of talking about the nature of research at Google is that we are not seeing ourselves as a place where we're looking into research results, and then throwing them off the fence for somebody else to pick up,' he said. 'The beauty is that this magic cycle is really part of what we're doing.'
He talked about teams looking at things like flood prediction,where he noted to so potential for future advancements.
We also briefly went over the issue of quantum computing,where Mathias suggested there's an important milestone ahead.
'We can actually reduce the quantum error, which is one of the hurdles, technological hurdles,' he said. 'So we see good progress, obviously, on our team.'
One thing Mathias noted was the work of Peter Shore, whose algorithm, he suggested, demonstrated some of the capabilities that quantum research could usher in.
'My personal prediction is that as we're going to get even closer to quantum computers that work, we're going to see many more use cases that we're not even envisioning today,' he noted.
Later, Mathias spoke about his notion that AI should be assistiveto humans, and not a replacement for human involvement.
'The fun part is really to come together, to brainstorm, to come up with ideas on things that we never anticipated coming upwith, and to try out various stuff,' he said.
Explaining how AI can fill in certain gaps in the scientific process, he described a quick cycle by which, by the time a paper is published on a new concept, that new concept can already be in place in, say, a medical office.
'The one area that I expect actually AI to do much more (in) is really (in) helping our doctors and nurses and healthcare workers,' Mathias said.
I was impressed by the scope of what people have done, at Google and elsewhere.
So whether it's education or healthcare or anything else, we're likely to see quick innovation, and applications of these technologies to our lives. And that's what the magic cycle is all about.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Associated Press
44 minutes ago
- Associated Press
MaxLinear and Comtrend Announce Availability of EV Charging Station Powerline Data Modules
CARLSBAD, Calif.--(BUSINESS WIRE)--Jun 2, 2025-- MaxLinear, Inc. (Nasdaq: MXL) and Comtrend announced today the availability of ITU-T standards-based powerline data modules for EV Charging Stations (EVSE) backend communication, including data centers and smart parking extensions. This press release features multimedia. View the full release here: MaxLinear's enables Comtrend's powerline data modules to accelerate EV Charger installations. Using MaxLinear technology (data-over-powerline), Comtrend's innovative powerline data module series collects and transfers data from power meters in EV charging infrastructure (EVSE) and IoT devices without the need for new cable installations. Comtrend leverages existing electrical powerlines for data communication, providing a scalable and hassle-free solution. This approach is particularly effective in underground concrete environments, where charging stations are frequently installed and other technologies lack reliability. Comtrend PM 1540 key benefits include: - No new wiring required – uses existing electrical wires for data transmission. - Lower latency, higher speeds, and greater stability than traditional methods. - Real-time connectivity. - Significant cost savings vs. LAN, Wi-Fi, or 4G solutions. - Simplified installation — reduced complexity, time, and no need for additional infrastructure. - Supports an electric wire domain of up to 250 nodes for large-scale deployments. - Strong signal transmission reaching up to 700 meters with up to 16 levels of signal repetition. For additional information on the Comtrend PM 1540: 'The electric vehicle industry has grown at an unprecedented rate in recent years. We are thrilled to partner with Comtrend to accelerate the installation of EV charging stations, addressing the industry's needs and meeting the rapidly increasing demand,' said Vikas Choudhary, Vice President of Connectivity and Storage Business at MaxLinear. Our product portfolio addresses a wide range of applications, including industrial IoT and Smart Grids, to proactively support the digital transformation of the industry.' 'Comtrend's Powerline Data Modules, powered by MaxLinear's cutting-edge technology, provide high-speed, secure, and reliable wired communication between EV charging stations and the smart grid,' said Vaclav Slehofer, Managing Director and Vice President of Comtrend Europe. 'By partnering with MaxLinear, we're bringing to market a cost-effective, easy-to-deploy and future-ready solution that ensures robust data connectivity for the evolving landscape of smart EV charging infrastructure.' Why MaxLinear for EV Charging? The versatility of the technology standard provides ultra-fast and reliable network connectivity for a wide range of markets and applications. works over any wiring infrastructure – coax, telephone wire, powerline, or Power-over-Fiber (POF). achieves very low latency while enforcing comprehensive Quality of Service (QoS) and delivering Gigabit speeds under any packet size. MaxLinear's baseband processors and analog front-end chipsets are fully ITU compliant and deliver physical data rates up to 2Gbps, the fastest performance in the industry. Deploying MaxLinear for EV charging stations enables seamless interoperability, efficiency, and low-cost deployments. Visit for an overview of MaxLinear's solutions. Why Comtrend for EV Charging? Comtrend EVSE solutions provide enhanced interoperability, integrating with various EV charging brands and smart grid systems, ensuring compatibility across different platforms and technologies. Comtrend's products are available now. For a full overview of Comtrend solutions for EV charging and other industrial IoT solutions, click here for more information. About MaxLinear, Inc. MaxLinear, Inc. (Nasdaq: MXL) is a leading provider of radio frequency (RF), analog, digital, and mixed-signal integrated circuits for access and connectivity, wired and wireless infrastructure, and industrial and multimarket applications. MaxLinear is headquartered in Carlsbad, California. For more information, please visit About Comtrend Comtrend has over 30 years of experience delivering high-quality broadband networking solutions to Service Providers. Comtrend offers a comprehensive lineup of solutions ranging from gateways to networking devices that provide clever coverage to innovative use cases or difficult-to-reach areas. Contact us today to learn more at Comtrend is a Member of the HomeGrid Forum. Cautionary Note About Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others, statements concerning or implying future financial performance, statements relating to MaxLinear's technology and the functionality, performance and benefits of such technology, statements about the potential market opportunity and rate of growth for MaxLinear's technology, statements relating to the partnership between MaxLinear and Comtrend, statements by our Vice President of Connectivity and Storage business and statements by the Managing Director and Vice President of Comtrend Europe. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to be materially different from any future results expressed or implied by the forward-looking statements and our future financial performance and operating results forecasts generally. Forward-looking statements are based on management's current, preliminary expectations and are subject to various risks and uncertainties. In particular, our future operating results are substantially dependent on our assumptions about market trends and conditions. Additional risks and uncertainties affecting our business, future operating results and financial condition include, without limitation; risks relating to the development, testing, and commercial introduction of new products and product functionalities; risks relating to our relationship with Comtrend; risks relating to our terminated merger with Silicon Motion and related arbitration and class action complaint and the risks related to potential payment of damages; the effect of intense and increasing competition; increased tariffs, export controls or imposition of other trade barriers; impacts of global economic conditions; the cyclical nature of the semiconductor industry; a significant variance in our operating results and impact on volatility in our stock price, and our ability to sustain our current level of revenue, which has previously declined, and/or manage future growth effectively, and the impact of excess inventory in the channel on our customers' expected demand for certain of our products and on our revenue; escalating trade wars, military conflicts and other geopolitical and economic tensions among the countries in which we conduct business; our ability to obtain or retain government authorization to export certain of our products or technology; risks related to the loss of, or a significant reduction in orders from major customers; costs of legal proceedings or potential violations of regulations; information technology failures; a decrease in the average selling prices of our products; failure to penetrate new applications and markets; development delays and consolidation trends in our industry; inability to make substantial research and development investments; delays or expenses caused by undetected defects or bugs in our products; substantial quarterly and annual fluctuations in our revenue and operating results; failure to timely develop and introduce new or enhanced products; order and shipment uncertainties; failure to accurately predict our future revenue and appropriately budget expenses; lengthy and expensive customer qualification processes; customer product plan cancellations; failure to maintain compliance with government regulations; failure to attract and retain qualified personnel; any adverse impact of rising interest rates on us, our customers, and our distributors and related demand; risks related to compliance with privacy, data protection and cybersecurity laws and regulations; risks related to conforming our products to industry standards; risks related to business acquisitions and investments; claims of intellectual property infringement; our ability to protect our intellectual property; risks related to security vulnerabilities of our products; use of open source software in our products; and failure to manage our relationships with, or negative impacts from, third parties. In addition to these risks and uncertainties, investors should review the risks and uncertainties contained in our filings with the Securities and Exchange Commission, including our Current Reports on Form 8-K, as well as the information to be set forth under the caption 'Risk Factors' in MaxLinear's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025. All forward-looking statements are based on the estimates, projections and assumptions of management as of the date of this press release, and MaxLinear is under no obligation (and expressly disclaims any such obligation) to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise. View source version on CONTACT: MaxLinear, Inc. Press Contact: Debbie Brandenburg Sr. Marketing Communications Manager Tel: +1 669.265.6083 [email protected] KEYWORD: CALIFORNIA EUROPE UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: HARDWARE IOT (INTERNET OF THINGS) DATA MANAGEMENT ENERGY GREEN TECHNOLOGY TECHNOLOGY EV/ELECTRIC VEHICLES ENVIRONMENT 5G AUTOMOTIVE SOFTWARE NETWORKS INTERNET UTILITIES MOBILE/WIRELESS SOURCE: MaxLinear, Inc. Copyright Business Wire 2025. PUB: 06/02/2025 03:05 AM/DISC: 06/02/2025 03:04 AM

Associated Press
44 minutes ago
- Associated Press
Dynamic Pricing Outperforms Time-of-Use in California EV Charging Pilot with 98% Energy Delivered Off-Peak
Dynamic pricing-based pilot with MCE and SVCE demonstrates enhanced flexibility and estimated $200/year average customer savings versus Time-of-Use Rates alone. PALO ALTO, CA, UNITED STATES, June 2, 2025 / / -- New results from a smart EV charging pilot, funded by the California Energy Commission's (CEC) REDWDS initiative and implemented by in partnership with MCE and Silicon Valley Clean Energy (SVCE), highlight the significant potential of dynamic price signals in optimizing EV charging. ChargeWise California's first phase tested how a dynamic approach can improve grid stability, lower energy costs, and boost renewable energy use in California. The findings highlight that dynamic price signals and automated charging management substantially improve managed EV charging compared to traditional Time-of-Use (TOU) rates. This approach delivered up to 98% EV charging load off-peak, significantly outperforming the 60-70% typically achieved by TOU rates alone, or the 90% by combining TOU with managed charging programs. Initial Pilot Insights: 1. Dynamic Approach Outperforms Time-of-Use for EV Loads: In addition to delivering 98% EV charging off-peak, ChargeWise California saved customers $10–20/month, shifted up to 30% of charging to solar-rich hours, and smoothed demand by avoiding the 'snapback' secondary peaks often triggered by rigid TOU schedules. 2. Lower Bills for Everyone: Dynamic pricing can save EV drivers ~$200 per year and reduce total system costs to lower utility bills for non-EV drivers. estimates aligning rates with grid-wide and local distribution signals will unlock over $1,000+ in annual system value per EV. 3. Whole-home Dynamic Rates are Inequitable: Applying dynamic rates to all customer load risks increased costs for customers without flexible tech like home batteries and EVs. ChargeWise California's submetering 'type-of-use' solution offered targeted incentives for EV charging, ensuring equity and high participation, with over 1,000 enrolled in 2 months, and over 50% from disadvantaged communities. 4. Programs Amplify Rates Impact: Dynamic rates amplify value when integrated with smart, customer-focused programs. ChargeWise California successfully combined dynamic pricing with automation in MCE and SVCE's managed charging programs, driving engagement to benefit both customers and the grid. 'Enrolling in MCE Sync was incredibly easy, and it has made managing my EV charging so simple. I love being able to track my energy consumption and see how much I'm saving each month. It's reassuring to know I'm charging with clean energy during off-peak times and making a positive impact, all while keeping more money in my pocket!', said Franco Maynetto, MCE Sync participant. 'The early results highlight just how impactful dynamic pricing can be in reshaping EV charging to support a cleaner, more flexible grid,' said Nick Woolley, CEO and Co-Founder of 'To fully realize the value of managed charging, we need an approach that is equitable, dynamic, system-aligned, and built through collaboration. That means designing solutions which precisely target flexible load, while making it easy for all customers to benefit—especially those in underserved communities. By utilities, aggregators, and policymakers working together in programs like ChargeWise California, we can create a path to unlock flexibility and deliver sustained reductions to electricity rates, with no negative consequences.' 'Silicon Valley Clean Energy is thrilled to see the insights and results coming out of this innovative dynamic pricing pilot,' said Monica Padilla, SVCE CEO. 'Helping our customers charge off-peak to lower their bills and align their charging with when energy is cleanest is not just valuable for our community, but for the broader California energy ecosystem.' 'As local electricity providers, the flexibility to innovate helps us meet the needs of our communities while advancing the California's clean energy goals. Combining targeted dynamic pricing with managed charging can significantly shift peak load and reduce costs, especially for residents and businesses in underserved communities. This pilot is proof that building partnerships with companies like backed by support from the CEC, is crucial for creating a dynamic, efficient, and equitable energy future for all Californians. We will continue to track the value of combining managed charging with dynamic versus time of use rates,' said Alice Havenar-Daughton, Vice President of Customer Programs at MCE. The initial findings demonstrate the crucial need for the energy industry to adopt a collaborative, holistic approach that considers all aspects of the energy system, including distribution, wholesale, capacity, and ancillary services. By prioritizing equitable program design and adaptive learning through testing, energy companies can optimize grid efficiency, integrate renewables, and lower customer bills. About is a Certified B Corporation® with a mission to make EV charging greener, cheaper, and smarter for utilities and their customers. Its end-to-end software platform wirelessly connects to a range of electric vehicles and chargers to intelligently manage EV charging while working with utilities to put cash back in customers' wallets for charging at grid-friendly times. With a global base of utility, vehicle OEM, and EVSE partners, manages more than 200,000 EVs on its platform each day. Learn more at About Silicon Valley Clean Energy Silicon Valley Clean Energy is a not-for-profit, community-owned agency providing electricity from renewable and clean sources to more than 280,000 residential and commercial customers in 13 Santa Clara County jurisdictions. As a public agency, net revenues are returned to the community to keep rates competitive and promote clean energy programs. Silicon Valley Clean Energy is advancing innovative solutions to fight climate change by decarbonizing the grid, transportation, and buildings. Learn more at About MCE MCE is a not-for-profit public agency and the preferred electricity provider for nearly 600,000 customer accounts and 1.5 million residents and businesses across Contra Costa, Marin, Napa, and Solano Counties. Setting the standard for clean energy in California since 2010, MCE leads with 60–100% renewable, fossil-free power at stable rates, serving a 1,400 MW peak load, significantly reducing greenhouse emissions, and reinvesting millions in local programs. For more information about MCE, visit or follow us on your preferred social platform @mceCleanEnergy. James Pratley +44 7940 369556 [email protected] Visit us on social media: LinkedIn Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Medscape
an hour ago
- Medscape
Centanafadine ‘Clinically Meaningful' for Adult ADHD
LOS ANGELES — The novel norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI) centanafadine (Otsuka Pharmaceutical Co., Ltd.) is effective and 'clinically meaningful' for adult attention-deficit/hyperactivity disorder (ADHD), new research suggested. In a combined analysis of two phase 3 trials with a total of 859 adults, more patients who received the NDSRI had at least an 18-point improvement at week 6 on the ADHD Investigator Symptom Rating Scale (AISRS) total scores compared with patients on placebo. Additionally, a significantly greater percentage of the active treatment groups showed improvement in the measure's hyperactivity/impulsivity and inattention subscales. Lenard A. Adler, MD But we weren't just interested in statistically significant change but in change 'that means something,' said principal investigator Lenard A. Adler, MD, director of the Adult ADHD program and professor of psychiatry at the New York University (NYU) Grossman School of Medicine, New York City. 'In other words: What do we know is a significant amount of change in patients receiving a compound? That's always a question because we want to get patients well and not just better,' Adler told Medscape Medical News . The findings were presented on May 19 at the American Psychiatric Association (APA) 2025 Annual Meeting. A high-dose, pediatric version of the drug was similarly effective for both children and adolescents in two additional phase 3 trials also presented at the meeting by Adler and colleagues. 'Gives a Benchmark' Centanafadine 'is a triple reuptake inhibitor, so it's not a classical stimulant,' said Adler. 'It's a compound that offers a unique profile.' Investigators pooled data from two identically designed phase 3 trials looking at the drug in patients with a primary diagnosis of ADHD. Together, this included 859 adult patients, with a mean age of 35 years (52% men; 80.3% White). The mean baseline total score on the semi-structured AISRS scale was 38.8 ('moderately ill'), with the mean AISRS inattention score 21.6 ('severely ill') and the mean AISRS hyperactivity/impulsivity score 17.2 ('moderately ill'). The AISRS is conducted as an interview between patient and clinician. 'We also recorded data on clinicians' global impression of severity and global impression of change and then used those as anchors to look at the clinically meaningful within-patient change for the AISRS,' co-investigator Caroline Ward, PhD, director of the Global Clinical Development at Otsuka Pharmaceutical Companies, told Medscape Medical News. All participants were randomly assigned to receive centanafadine at 200 mg (n = 287) or 400 mg (n = 287) or a matching placebo (n = 285). Results showed that the mean change on the AISRS total score at week 6 was −12.1 and −12.5 for the centanafadine 200 mg and 400 mg groups, respectively, vs −8.1 for the placebo group ( P = .002 and .0009). In addition, 24% of the 200 mg group and 25.4% of the 400 mg group achieved an 18-point or greater improvement in AISRS total score from baseline to week 6 compared with 15.4% of the placebo group (ratio of response rate [RR], 1.70; P = .002 and RR, 1.71; P = .001, respectively). A 10-point or greater improvement on the AISRS inattention subscale was achieved by 26.1% of the 200 mg group and 23.3% of the 400 mg group compared with 16.5% of the placebo group (RR, 1.71; P = .001 and RR, 1.45; P = .03, respectively); and an 8-point or greater improvement on the hyperactivity/impulsivity subscale was achieved by 26.5% and 28.6% of the 200 mg and 400 mg groups, respectively, compared with 20% of the placebo group (RR, 1.38; P = .03 and RR, 1.47; P = .01, respectively). The 200 mg and 400 mg groups also reached the 'clinically meaningful within-patient change AISRS threshold' for the first time earlier than the placebo group ( P = .0006 and P < .0001, respectively). Looking at meaningful change 'gives clinicians a benchmark,' said Adler. Pediatric Safety and Efficacy The investigators also presented results from two other randomized phase 3 trials that assessed the drug in children between the ages of 6 and 12 years (n = 480; 58% boys) and adolescents between 13 and 17 years (n = 459; 59% boys). Of these, 77% and 81%, respectively, completed their studies. All were from the United States and Canada. The adolescents received high-dose centanafadine (328.8 mg once daily), low-dose centanafadine (164.4 mg once daily), or placebo for 6 weeks. The children received a placebo or a high or low dose of centanafadine, with doses based on their weight. A larger number of children who received high-dose centanafadine had an 18-point or greater improvement at week 6 on the ADHD Rating Scale–5 (ADHD-RS-5) total score compared with the children who received placebo (34.5% vs 23.3%; P = .03), with even stronger effects found in the adolescents (47.7% vs 31.7%; P = .004). A greater number of the high-dose active treatment group vs the placebo group also had at least a 10-point improvement in ADHD-RS-5 inattention subscale scores (children, P = .03; adolescents, P = .003) and at least an 8-point improvement in hyperactivity/impulsivity subscale scores ( P = .04 and .03, respectively). In addition, the mean change from baseline to week 6 on the ADHD-RS-5 total score was −16.3 for the children receiving the high-dose drug vs −10.8 for those receiving placebo ( P = .0008) and was −18.5 vs −14.2 in the adolescents ( P = .0006). When assessing caregiver-rated improvements, investigators found that a greater number of children and adolescents receiving high-dose centanafadine vs placebo achieved at least a 14-point improvement on the Conners 3–Parent Short Inattention T-scores ( P = .02 and .001, respectively) and at least a 13-point improvement on the Conners 3–Parent Short Hyperactivity/Impulsivity T-scores ( P = .02 and .007, respectively). Most treatment-emergent adverse events were deemed to be mild to moderate. The most common adverse events in the high-dose centanafadine group were decreased appetite and rash in the children and decreased appetite, rash, nausea, and headache in the adolescents. Ward reported that data from these studies, along with some they conducted previously and some that are ongoing, will be part of a package they're preparing to send to the US Food and Drug Administration in the near future. Altogether, 'it tells a nice story,' she said. Real-World Data Commenting for Medscape Medical News, Soonjo Hwang, MD, associate professor of psychiatry at the University of Nebraska Medical Center, Omaha, Nebraska, noted that among treatments already available for ADHD, the most well-known are stimulant medications, which 'are purely' dopaminergic reuptake inhibitors. Soonjo Hwang, MD 'That said, norepinephrine, dopamine, and serotonin have a close relationship with each other in the brain. So, if you inhibit one, it will have an impact on the others as well,' said Hwang, who was not involved with the new research. He pointed out that centanafadine has a similar profile to other medication groups, such as antidepressants, that have been assessed previously for ADHD. 'In terms of the mechanism, it's similar to some we've had in the past. Still, it is really important for us to have new tools to treat this disorder because we currently have limited options,' Hwang said. He noted that being 'clinically meaningful' is a concept worth thinking about. 'This was a randomized-controlled clinical trial that [focused] towards more real-world data. And it's important to have data on how the medication performs in a real-world situation before launching it to market,' he said. Hwang added that he'd also like to know, moving forward, how well the medication works in patients with comorbidities, which is common in those with ADHD.